E-Commerce Helping Pet Owners get Their Paws on #CBD #Pet Products (CSE:
$CURA.C) (OTC: $LRSV) (CSE: $VIDA.C) (OTC: $PHVAF) (OTC: $ELLXF)
Point Roberts WA, Delta BC – June 7, 2019 - Investorideas.com, a leading investor news resource covering hemp and
cannabis stocks releases a sector snapshot reporting on the CBD pet market as
more companies enter the sector with a heavy focus on e-commerce sales.
Read this in full
at https://www.investorideas.com/news/2019/cannabis/06073CBDPetProducts.asp
Curaleaf Holdings, Inc. (CSE: CURA) (OTC: CURLF), a leading vertically integrated cannabis
operator in the United States recently announced the launch of Bido hemp-based CBD products
for pets. CBD has been shown in initial third-party studies to support a pet's
overall wellness, including the potential to help manage pain and anxiety. Bido
Pet Drops come in three varieties, bacon, salmon and unflavored
"pure," and Bido Soft-baked Bites are available in apple chicken,
peanut butter bacon, and honey sweet potato. All Bido products can be purchased
online at www.curaleafhemp.com.
Bido's tasty products
were developed using 100 percent natural and US grown hemp that was tested and
extracted to the highest industry standards. Curaleaf's team of scientists transformed
the hemp-based CBD oil into a product with a precise dosage and flavor for
pets.
All Bido products
undergo strict laboratory testing before formulation as well as batch testing
on the final products before distribution. Lab results are available upon
request.
"Our human
customers are already reaping the benefits of CBD with Curaleaf Hemp. The same
care and research went into the development of Bido. We are excited to be
extending our high quality, trusted products to pet owners," said Joe
Lusardi, President and Chief Executive Officer of Curaleaf. "The launch of
Bido is just one more way we are the most accessible cannabis company in the
US."
In a recent New York Post article, “New York dogs and cats are turning
to pot to deal with ailments like chronic pain and seizures - and just to
mellow out after a long day walking for The Man, according to their owners and
dealers.”
“Phoebe is a little high-strung and it kind of takes the edge off her -
like adults,” Long Islander John P. Delafuente, 37, told The Post of his
Cockalier’s habit for CBD-infused dog biscuits.
“She has a hard day in the city, a lot of noises and other dogs barking.
We recently started giving her biscuits and she just chills,” he said.
Ronnie Almani, the owner of West Village CBD store, Hemped says his
CBD-infused chicken biscuits and steak bites are flying off the shelves.
LinkResPet, a
subsidiary of Link Reservations Inc.
(OTC: LRSV), a company providing Cannabidiol (CBD)
products especially tailored for pets, announced the launch of its e-commerce site, allowing consumers
in the US and Canada to be able to purchase LinkResPet’s CBD products for dogs,
cats and horses on www.linkrespet.com, which was purchased in February 2019.
Pet owners are
increasingly going online for their pet’s needs and products. A recent report
noted that 40% of pet owners in the US purchase pet products from online retailers.
It’s easy to understand the rise in e-commerce, with benefits for consumers
including the increased variety and availability of options, greater
accessibility, and ease of delivery to their homes. Taking this onboard, LRSV’s
LinkResPet site will be transformed into an e-commerce platform, allowing
customers to buy CBD products for dogs, cats and/or horses from the comfort of
their device.
“For us, it makes
absolute sense to enter the CBD B2C market with an e-commerce platform. There
is a huge opportunity for LinkResPet, with the number of people increasingly
buying products online and further ease and accessibility,” explained Rene
Lauritsen, Link Reservations Inc. CEO. “We are focused on delivering the
highest quality product in the most approachable way for the customer, having
an e-commerce platform is the first step for that. Beyond being easy to control
and maintain, starting with e-commerce ensures that we remain dedicated to the
product quality and swift experience for the customer as opposed to intricate
logistics that arise from brick and mortar shops.”
In fact, e-commerce
is becoming the most popular shopping medium in key territories. According to Absolunet, e-commerce is expected to account for 15%
of all specialty retail sales in North America, with digital influencing nearly
60% of all retail sales. Mobile helped fuel sales, which increased 55% in a
year, while e-commerce in the region grew by 16% in 2018 to over $500 billion.
Europe is also proving a fruitful market for e-commerce. According to Emarketer.com, ecommerce sales in the EU-5 (France, Germany,
Italy, Spain and the UK) are expected to exceed $325 billion this year and
surpass $400 billion in 2022.
“The key aspect for
us is that our LinkResPet e-commerce site will ensure people are not only able
to easily find the product they need, but also find a variety of information on
the site, while browsing from their preferred device without having to go out
of their way to find it,” added Lauritsen.
Additionally, the
company will also offer subscription options, which would allow customers to get
a package of CBD treats for their pets each month or quarter. Pet owners would
be able to curate their own product boxes with the treats their pet likes best
and have a recurring order with their preferences.
On this, Lauritsen
explained, “Now that the site is live, we are aiming to trial different
subscription options and see if they are the best fit for our customer. This
aligns with our mission of making high-quality CBD products accessible to pet
owners. In our eyes, it simplifies things and ensures they get the products
they need on a regular basis so they never run out. A subscription option is
one of the many choices we want to put in front of customers, along with
curated packages and potentially a referral system, to make sure we are
catering for both their needs and their pet’s.”
Phivida Holdings Inc. (CSE:VIDA) (OTC:PHVAF), a premium producer of CBD/ Active Hemp
Extract infused functional beverages and health supplements recently announced that they intend to introduce a range of
hemp-derived CBD pet products. With a strong focus on providing consumers with
a healthy alternative to pharmaceuticals, and a fully natural and plant-based
health and wellness solution, Phivida's new product line will provide a similar
offering to pets.
"Our mission is
to provide the highest quality Hemp CBD natural wellness products for our
consumers," says Jim Bailey, President and CEO of Phivida. "By
expanding into the pet CBD category, our goal is to provide pet owners with the
option to support their pets' wellness needs for everything from sleep to
stress reduction."
Research conducted by
Nielson has estimated that Americans spent $33 billion on pet foods and treats
alone in 2017. According to the Brightfield Group, CBD pet product sales
increased from $8 million to $32 million in the last two years and is poised to
reach $1.16 billion by 2022.
Initially, the new
product range will consist of tinctures in three concentrations formulated for
small, medium and large pets as well as an oral spray. Pet treats are planned
to be introduced to the market as the US Food and Drug Administration clarifies
the regulations around edible CBD products.
"Myself and many
of our team are pet owners," added Mr. Bailey. "It is very important
to all of us that these valued family members have all the support they need to
enjoy a high quality of life. The products will be produced to the same high
standards as those for human consumption, and we are committed to listening to
pet owners and extending the offering to meet their needs."
Elixinol Global Limited (OTC: ELLXF) (ASX: EXL), one of the most influential CBD brands in the
world, with nearly three decades of experience in the hemp industry announced earlier in the month that they have
purchased a 25 percent stake in Altmeds LLC, maker of the pioneering and market
leading Pet Releaf hemp-derived CBD pet line. Pet Releaf sales accounted for approximately
65 percent of the market’s pet CBD sales last year.
Pet Releaf
hemp-derived CBD topical, edibles and oils for pets currently sell in over
4,000 independent pet stores throughout the USA and multiple international
markets. By acquiring a stake in Pet Releaf, Elixinol will strengthen its
relationship with a major private label partner and secure a profitable
investment in the fast-growing hemp-derived CBD pet products market, while
ensuring Pet Releaf has the financial resources to innovate, expand and scale.
“Pet Releaf and
Elixinol share the same values in sourcing and end-product superiority,” said
Stephen Smith, President and Co-Founder of Pet Releaf. “The partnership of two
best-in-class companies means Pet Releaf will gain additional working capital
to be able to expand our reputation for innovation, and increase our scientific
and international expertise while still maintaining our ‘from seed to sale from
plant to pet™’ approach.”
Elixinol is the
exclusive supplier of final hemp extract sourced from the USDA Organic
certified hemp strain grown specifically for Pet Releaf. The founders of Pet
Releaf and Elixinol have shared scientific, farming and production ideas,
expertise and strategy for many years. Since inception, Pet Releaf has been a foundational
customer of Elixinol with both organizations starting in Colorado in 2014.
Together, the two strong brands leverage seed to sale supply chain efficiencies
with extensive scalability, in-house scientific expertise and proprietary
processing technologies.
Pet Releaf will use
the majority of the investment to fund working capital and scale the business
for expected continued growth in the market, through new product lines, key
strategic hires and increased capacity in a new state of the art 25,000
square-foot production facility.
“Pets play an
important role in the lives of many Elixinol customers,” added Chris Husong, VP
of marketing and communications at Elixinol. “Pet Releaf products give pet
owners peace of mind by using the same quality CBD hemp in their pet treats as
Elixinol uses in our human products. We’re excited to strengthen the
relationship with trusted pet products brand and partner, Pet Releaf.”
The CBD pet space has
been a hot topic for several months now, and there is a lot of anticipation and
expectation around how big this market will grow, but now with real products on
the market and consumer accessibility improved through e-commerce, we will soon
have tangible results for this sector. E-commerce access is now available for US
and Canadian consumers and it’s up to our furry companions to choose which
brand(s) will see proper sales growth in the coming months.
About Investorideas.com - News that Inspires Big
Investing Ideas
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. Disclosure: this news
article featuring LRSV is a paid for news release on Investorideas.com. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing
your news release and our other news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere
to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Contact Investorideas.com
800-665-0411
Get
more Marijuana, hemp & cannabis stock investor ideas- news, articles, podcasts and stock directories
